MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Gain Therapeutics, Inc. Common Stock

GANX

#3291
Gain Therapeutics, Inc. Common Stock
2.61
+7.85%
Sector:
Base:
Profit Currency:
Daily Range
2.61
2.61
Year Range
1.41
4.34
Daily Change
+7.85%
Monthly Change
+26.70%
6 month change
+38.83%
Year Change
+30.50%
Previous Close
2.42
Open
2.61
Bid
Ask
Low
2.61
High
2.61
Volume
16
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. GANX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Investing Investing
GANX
2026.01.06
Gain Therapeutics reports 81% reduction in Parkinson’s biomarker
Benzinga Benzinga
GHRS RGC SIDU CNTX PBF
2026.01.05
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)
Zacks Zacks
GANX
2025.12.22
Gain Therapeutics (GANX) Upgraded to Buy: Here's Why
Investing Investing
AMZN NVDA MSFT PG CVX
2025.12.18
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%
Zacks Zacks
EHAB GANX
2025.12.18
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Zacks Zacks
GANX
2025.12.08
Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy
Investing Investing
GANX
2025.12.01
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data
Investing Investing
GANX
2025.11.28
Gain Therapeutics files prospectus supplement for $35.5 million stock offering
Zacks Zacks
GANX
2025.11.17
Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know
Investing Investing
GANX
2025.10.17
Gain Therapeutics stock rating reiterated at Buy by H.C. Wainwright
Investing Investing
GANX
2025.10.06
Gain Therapeutics reports preliminary Phase 1b data for Parkinson’s drug GT-02287
Investing Investing
GANX
2025.10.06
Gain Therapeutics reports positive early data from Parkinson’s trial

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd